Clas Malmeström

Clas Malmeström serves as an Associate Professor at the University of Gothenburg's Sahlgrenska Academy and works as a Senior Physician in Neurology and Clinical Immunology at Sahlgrenska University Hospital. His research and clinical practice focus on neuroimmunological disorders, particularly multiple sclerosis and related conditions.

Dr. Malmeström's research interests span multiple critical areas in neuroimmunology. His work extensively investigates biomarkers in cerebrospinal fluid and serum for diagnosing and monitoring neurological conditions, with particular focus on neurodegeneration processes in multiple sclerosis. He has made significant contributions to understanding the roles of neurofilament light chain, glial fibrillary acidic protein, and kappa free light chains as indicators of disease activity and progression. His research also examines the effects of disease-modifying therapies on neuroinflammation and explores autoimmune mechanisms in conditions like NMOSD and MOGAD.

Dr. Malmeström's scientific contributions are reflected in numerous high-impact publications spanning multiple areas of neuroimmunology. His work demonstrates consistent focus on translating biomarker research into clinical applications, with recent studies examining real-world treatment outcomes, diagnostic accuracy of novel biomarkers, and the intersection of infectious diseases with neurological autoimmunity.

His collaborative approach is evident through extensive co-authorship with colleagues at the University of Gothenburg and Sahlgrenska University Hospital, particularly with researchers including Jan Lycke, Markus Axelsson, and Lenka Novakova. This collaborative network has produced significant research on treatment efficacy, biomarker validation, and autoimmune mechanisms in neurological disorders.

At Sahlgrenska University Hospital, Dr. Malmeström contributes to clinical care for patients with complex neuroimmunological conditions, bridging his research expertise with direct patient care. His position as both academic researcher and senior physician allows him to address critical questions at the intersection of clinical practice and scientific investigation in neuroimmunology.